Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese investigators identify Toll-like receptor antagonists

Feb. 22, 2022

Discovery of KP-1, an antifibrotic peptide that ameliorates renal fibrosis in vivo

Feb. 22, 2022

Betta Pharmaceuticals discloses PD-1/PD-L1 interaction inhibitors

Feb. 22, 2022

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Feb. 22, 2022

New curcumin derivatives show activity against non-small lung cancer

Feb. 22, 2022

CC40.8 antibody confers protection against SARS-CoV-2 infection

Feb. 22, 2022

LCDR regulates lysosomal function through stabilization of LAPTM5 and promotes cancer cell survival

Feb. 22, 2022

"Twin study" of sorts brings insight into arthritis microbiome

Feb. 21, 2022

GR-3027 reverses neuroinflammation in rat model of hyperammonemia

Feb. 21, 2022

SIGMAR1 targeting ameliorates preclinical Wolfram syndrome symptoms

Feb. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...